Skip to main content
. 2017 Mar 6;4(1):89–94. doi: 10.1016/j.jcmgh.2017.02.009

Table 1.

Evidence for Cellular Origins of Metaplasia

Evidence for chief cells Evidence for Mist1+ isthmus stem cells
Proliferation None in normal state, and minimal (<5%) in injury Normally slow proliferation, and marked expansion in injury
BrdU labeling No uptake in normal state, with rare labeling after injury (eg, 5-FU), but no upward migration8 Labeled cells migrate bidirectionally from the isthmus upward toward the pits and downward to the base
Lineage tracing Troy-derived long-term tracing in haploinsufficient Troy knockin models,8 but not in Troy BAC models6
Chief cells express Lgr5, but no tracing from Lgr5+ chief cells in normal and injury states9; ablation of Lgr5+ chief cells does not decrease Mist1-derived tracing6
No evidence that chief cells expand clonally
Mist1-CreERT labels the isthmus stem cell as well as chief cells, and tracing arises from the isthmus stem cell6
5-FU–induced stem cell ablation eliminates Mist1 tracing6
Confetti mice show clonal expansion from the isthmus6
eR1-CreERT mice show lineage tracing from the isthmus10
DMP-777 TFF2+IF+ cells present in lower third of glands after treatment, but morphology of these SPEM cells is atypical and changes are transient (<2 wk)
DMP-777 reduces Mist1-traced chief cell number5, 6
Mist1+ isthmus stem cell–derived tracing is not altered after DMP-7776
Human gastric metaplasia is stable and clonal with a field effect, indicating stem cell origins3
Mutant Kras Proliferating GS2+IF+ cells at the base after 1 month7
eR1-CreERT with Kras mutation leads to occasional GS2+ metaplasia near the gland base10
Most chief cells do not proliferate even after Kras induction at early time points, and are replaced rapidly by the migration of isthmus-derived SPEM cluster
Mucous-producing proliferating GS2/MUC6+ SPEM that is Alcian blue+ is present early on only in the isthmus
Gland fission is present early only in the isthmus
Lgr5-DTR–mediated ablation of chief cells does not reduce metaplasia, whereas suppression of the isthmus stem cell (with 5-FU) blocks metaplasia6
Metaplasia in eR1-CreERT;LSL-Kras mice starts primarily in the isthmus10

BrdU, bromodeoxyuridine; 5-FU, 5-fluorouracil.